Skip to content
StockMarketAgent
Direct answer
MAR trades against a final fair-value range of $151.90-$303.69, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs. Fair value range: low $152, high $304, with mid-point at $228.
Stock analysis

MAR fair value $152–$304

By StockMarketAgent.AI team· supervised by
Przeanalizowano: 2026-05-20Następna aktualizacja: 2026-08-20Methodology v2.4Data cut-off: Quality gate: passSources: all material sources passed deterministic freshness/provenance gatesReview: automatedArchetype: Mature compounder
View archive
Cena
$358.69
▼ -130.85 (-36.48%)
Wartość godziwa
$228
$152–$304
Rekomendacja
Sprzedaj
confidence 88/100
Potencjał wzrostu
-36.5%
upside to fair value
Margines Bezpieczeństwa
$193.66
MoS level · 15%
Kapitalizacja
$94.6B
P/E fwd 27.4
Awaryjny angielskiPL
Pokazujemy źródło angielskie podczas tłumaczenia
Ten raport nie został jeszcze przetłumaczony. Odśwież za kilka minut, gdy kolejka tłumaczeń go przetworzy.

§1 Podsumowanie wykonawcze

  • Composite fair value $228 with high case $304.
  • Implied downside of 36.5% to fair value.
  • Moat 9/10 · confidence 88/100 · Mature compounder.
  • Currently screens above fair value, so patience matters more than entry speed.
Fair value
$228
Margin of safety
-57.4%
Confidence
88/100
Moat
9/10

Educational analysis only — not financial advice. Always do your own due diligence.

$358.69Price
Low $151.9
Mid $227.84
High $303.69

MAR trades against a final fair-value range of $151.90-$303.69, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs.

  • Dominant Bonvoy loyalty ecosystem locking
    Dominant Bonvoy loyalty ecosystem locking in high-value corporate travelers.
  • Global scale and brand portfolio
    Global scale and brand portfolio yielding immense pricing power.
  • Cycle upside
    Global travel demand outstrips limited supply pipelines, driving aggressive ADR (Average Daily Rate) and RevPAR expansion across upscale portfolios.

§2 Scenariusz negatywny

A severe macroeconomic contraction compresses RevPAR, while sustained high interest rates raise the cost of servicing $17B in debt, forcing a halt to share buybacks and destroying EPS growthEPS growthYear-over-year change in diluted earnings per share. The bottom-line growth rate that drives shareholder return when multiples are stable. momentum.

Jak ta teza może się załamać

Interest Rate Shock & Refinancing Squeeze

· Medium

Cost of debt spikes on the $17B load, forcing cash diversion from the buyback engine to debt service, collapsing the EPS accretion thesis.

FV impact
-30%
Trigger
12-24 months

Valuation Multiple Mean Reversion

· High

Market pivots from pricing MAR as a perpetual compounder to a cyclical lodging stock, instantly closing the gap to the intrinsic $227.84 fair value.

FV impact
-36%
Trigger
0-12 months

Structural Corporate Travel Decline

· Low

Permanent downward shift in enterprise travel budgets reduces high-margin group bookings, structurally compressing system-wide RevPAR.

FV impact
-15%
Trigger
24-36 months
Sygnały wczesnego ostrzegania do monitorowania
WskaźnikBieżącyPróg wyzwalania
Consecutive quarters of RevPAR growth trailing the baseline 6.4% estimate.MonitorDeterioration versus the report thesis
Rising debt-to-EBITDA ratio exceeding 4.0x.MonitorDeterioration versus the report thesis
Suspension or material reduction of the share repurchase program.MonitorDeterioration versus the report thesis
Contraction in the net global pipeline of room additions.MonitorDeterioration versus the report thesis
Erosion of Bonvoy active member engagement metrics.MonitorDeterioration versus the report thesis

§3 Historia finansowa

Rachunek zysków i strat — ostatnich sześć okresów
PozycjaT−0T−1T−2T−3CAGR
Okres2022-12-312023-12-312024-12-312025-12-31Trend
Przychody$20.77B$23.71B$25.10B$26.19B+8.0%
Zysk brutto$4.56B$4.98B$4.97B$5.22B+4.6%
Zysk operacyjny$3.47B$3.92B$3.84B$4.14B+6.0%
Zysk netto$2.36B$3.08B$2.38B$2.60B+3.3%
EPS (rozwodniony)$7.24$10.18$8.33$9.51+9.5%
EBITDA$3.92B$4.38B$4.34B$4.80B+7.0%
R&D—————
SG&A$891.0M$867.0M$945.0M$870.0M-0.8%

Wyniki jakości

Wskaźnik Piotroski F
7 / 9
Złożony wynik jakości 0–9
Wskaźnik Altman Z
3.99
Ryzyko upadłości (>3 bezpieczne)
Wskaźnik Beneish M
-2.55
Ryzyko manipulacji wynikami
OCF / Zysk netto
1.24×
>1 wskazuje wysoką jakość wyników
Bramka jakości księgowej
Pass
Bramka skorygowana o sektor
ROIC
24.9%
Zwrot z zainwestowanego kapitału
Sekcja 3

Numbers analysis

Przepływy pieniężne

Cash-flow quality is reflected in the OCFOperating cash flowCash generated from the company's core operations after working-capital changes but before capital expenditures. The first line of the cash-flow statement. / net incomeNet IncomeNet Income is an income-statement line item used to reconcile revenue to operating profit, pre-tax income, net income, or per-share earnings. It should be compared across periods and against peer disclosure conventions., accounting-quality, and ROICROICReturn on invested capital. Operating profit (after tax) divided by invested capital. The single best gauge of capital-efficiency. Spread over WACC = economic value created. rows above.

Alokacja kapitału

Capital allocation should be evaluated against reinvestment needs, balance-sheet strength, and shareholder returns.

Subskrybenci indywidualni — od §411 kolejnych sekcji

Przeczytaj pełną analizę — 11 kolejnych sekcji.

Competitive moat, industry cycle, peer comparison, intrinsic valuation, sensitivity, scenarios, earnings decision tree, position management, investor perspectives, scorecard, and final recommendation.

Pełny raport dla każdego pokrytego tickera
24 miesiące archiwum rekomendacji
Briefingi watchlisty + alerty zmian rekomendacji
Eksport PDF + DOCX w dowolnym języku
Rozpocznij darmowy okres próbny
Anuluj w dowolnym momencie.
FAQ

MAR — frequently asked questions

  1. Based on our latest analysis, MAR looks meaningfully overvalued. The current price is $359 versus a composite fair-value midpoint of $228 (range $152–$304), which implies roughly 36.5% downside to the midpoint.

Related coverage

Names readers of MAR also follow

Same archetype: mature-compounder